FIELD: application of alkyl-resorcinol as a cytoprotective agent.
SUBSTANCE: use of alkyl-resorcinol with an alkyl chain length from 4 to 12 carbon atoms has been proposed at a concentration of 10-5 M/l, 10-6 M/l or 10-7 M/l as a cytoprotective agent that increases the expression of arginase 1 and indoleamine -pyrrole-2,3-dioxygenase genes (ARG1) in cells.
EFFECT: effective elimination of the damaging effects of the inflammatory process on healthy tissue surrounding the inflammatory locus.
1 cl, 3 dwg, 4 tab, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIMICROBIAL PREPARATIONS COMPOSITION FOR PEOPLE AND ANIMALS INFECTIOUS DISEASES TREATMENT AND METHOD OF ITS ADMINISTRATION | 2017 |
|
RU2665006C1 |
| METABIOTIC COMPOSITION TO ENSURE COLONISATION RESISTANCE OF HUMAN INTESTINAL MICROBIOCENOSIS | 2015 |
|
RU2589818C1 |
| METHOD FOR ASSESSING MUCOSAL IMMUNITY STATE OF OPEN CAVITIES OF DIFFERENT LOCALISATION ACCOMPANYING PREDICTION OF CLINICAL COURSE OF INFECTIOUS-INFLAMMATORY PROCESSES, AND METHOD FOR CORRECTING INFECTIOUS-INFLAMMATORY PROCESSES | 2014 |
|
RU2556958C1 |
| LOCAL AND EXTERNAL PHARMACEUTICAL PRODUCT BASED OF LOW MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2353354C1 |
| PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL USE, BASED ON LOW-MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2348400C1 |
| PHARMACEUTICAL INJECTION COMPOSITION ON BASIS OF TILORONE FOR TREATMENT OF PURULENT-DESTRUCTIVE PROCESSES WITH SIGNS OF IMMUNE INSUFFICIENCY | 2007 |
|
RU2359664C1 |
| PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL APPLICATION ON BASIS OF LOW-MOLECULAR INDUCTOR OF INTERFERON | 2007 |
|
RU2352330C1 |
| PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL APPLICATION BASED ON LOW-MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2351322C1 |
| LOCAL APPLICATION OF DIOXYDINE IN INFECTIOUS-INFLAMMATORY EPITHELIAL AFFECTION | 2019 |
|
RU2726982C1 |
| MAMMAL MILK CELLS, COMPOSITIONS CONTAINING THEM, AND USING THEM FOR TREATING MASTITIS | 2008 |
|
RU2446814C2 |
